Rankings
▼
Calendar
IVVD Q2 2025 Earnings — Invivyd, Inc. Revenue & Financial Results | Market Cap Arena
IVVD
Invivyd, Inc.
$257M
Q2 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$12M
+420.6% YoY
Gross Profit
$11M
94.2% margin
Operating Income
-$15M
-127.8% margin
Net Income
-$15M
-124.4% margin
EPS (Diluted)
$-0.12
QoQ Revenue Growth
+4.3%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$13M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$89M
Total Liabilities
$46M
Stockholders' Equity
$43M
Cash & Equivalents
$35M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$12M
$2M
+420.6%
Gross Profit
$11M
$2M
+410.2%
Operating Income
-$15M
-$49M
+69.4%
Net Income
-$15M
-$47M
+69.0%
Revenue Segments
Product
$12M
100%
← FY 2025
All Quarters
Q3 2025 →